文献速递认知障碍与痴呆

载脂蛋白E ε4与阿尔茨海默病痴呆多基因风险对淀粉样蛋白和认知的可分离影响

Dissociable influences of APOE ε4 and polygenic risk of AD dementia on amyloid and cognition.
PubMed 文献 · Neurology · 2018-03-28

研究纳入702名参与者(221名临床正常、367名轻度认知障碍、114名阿尔茨海默病痴呆),分析载脂蛋白E ε4状态和多基因风险评分与纵向β-淀粉样蛋白、认知及海马体积的关系。载脂蛋白E ε4与基线β-淀粉样蛋白强相关,而多基因风险评分仅弱相关;在β-淀粉样蛋白阳性者中,载脂蛋白E ε4与记忆下降和海马萎缩相关,控制载脂蛋白E ε4后多基因风险评分与认知下降相关。作者认为遗传风险与β-淀粉样蛋白存在协同交互,结合基线β-淀粉样蛋白可能改善临床试验富集策略。

要点

  • 载脂蛋白E ε4与基线β-淀粉样蛋白强相关,多基因风险评分与之仅弱相关。
  • β-淀粉样蛋白阳性者中,载脂蛋白E ε4与记忆下降和海马萎缩相关。
  • 控制载脂蛋白E ε4后,多基因风险评分与β-淀粉样蛋白阳性者认知下降相关。

核心结论

  • 阿尔茨海默病痴呆的遗传风险因素既表现出与β-淀粉样蛋白相关的作用,也表现出与β-淀粉样蛋白的协同交互。
  • 携带较高遗传风险的β-淀粉样蛋白阳性个体认知下降更快的特定效应,可能解释β-淀粉样蛋白阳性个体认知轨迹的高度异质性。
  • 结合基线β-淀粉样蛋白考虑遗传变异,可能改善针对最可能出现认知下降的β-淀粉样蛋白阳性个体的临床试验富集策略。

研究设计与样本

  • 研究分析了702名有遗传数据和氟倍他吡正电子发射断层扫描的参与者,其中221名临床正常、367名轻度认知障碍、114名阿尔茨海默病痴呆。
  • 669名参与者的子集额外有纵向磁共振成像扫描以评估海马体积。
  • 多基因风险评分基于既往大规模全基因组关联研究的汇总统计量估算。

主要发现

  • 载脂蛋白E ε4与基线β-淀粉样蛋白强相关,而多基因风险评分与基线β-淀粉样蛋白仅存在弱关联。
  • 在β-淀粉样蛋白阳性参与者中,载脂蛋白E ε4还与更大的记忆下降和海马萎缩相关。
  • 控制载脂蛋白E ε4后,多基因风险评分与β-淀粉样蛋白阳性参与者的认知下降相关。
  • 多基因风险评分与β-淀粉样蛋白阴性参与者的海马萎缩相关,并与β-淀粉样蛋白阳性参与者的基线海马体积弱相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the effects of genetic risk of Alzheimer disease (AD) dementia in the context of β-amyloid (Aβ) accumulation. METHODS: We analyzed data from 702 participants (221 clinically normal, 367 with mild cognitive impairment, and 114 with AD dementia) with genetic data and florbetapir PET available. A subset of 669 participants additionally had longitudinal MRI scans to assess hippocampal volume. Polygenic risk scores (PRSs) were estimated with summary statistics from previous large-scale genome-wide association studies of AD dementia. We examined relationships between APOE ε4 status and PRS with longitudinal Aβ and cognitive and hippocampal volume measurements. RESULTS: APOE ε4 was strongly related to baseline Aβ, whereas only weak associations between PRS and baseline Aβ were present. APOE ε4 was additionally related to greater memory decline and hippocampal atrophy in Aβ+ participants. When APOE ε4 was controlled for, PRS was related to cognitive decline in Aβ+ participants. Finally, PRSs were associated with hippocampal atrophy in Aβ- participants and weakly associated with baseline hippocampal volume in Aβ+ participants. CONCLUSIONS: Genetic risk factors of AD dementia demonstrate effects related to Aβ, as well as synergistic interactions with Aβ. The specific effect of faster cognitive decline in Aβ+ individuals with higher genetic risk may explain the large degree of heterogeneity in cognitive trajectories among Aβ+ individuals. Consideration of genetic variants in conjunction with baseline Aβ may improve enrichment strategies for clinical trials targeting Aβ+ individuals most at risk for imminent cognitive decline.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Ge T, Sabuncu MR, Smoller JW, et al. Dissociable influences of APOE ε4 and polygenic risk of AD dementia on amyloid and cognition. Neurology. 2018. PMID: 29592889. doi:10.1212/WNL.0000000000005415

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。